{"id":1200,"date":"2022-08-15T11:23:04","date_gmt":"2022-08-15T09:23:04","guid":{"rendered":"https:\/\/semmelweis.hu\/tmk\/?page_id=1200"},"modified":"2025-11-20T13:44:13","modified_gmt":"2025-11-20T12:44:13","slug":"budai-kinga","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/tmk\/2022\/08\/15\/budai-kinga\/","title":{"rendered":"Budai Kinga"},"content":{"rendered":"

\"\"Semmelweis University, University Pharmacy, Institute of Pharmaceutical Organisation<\/h4>\n
\n
TOPIC<\/strong><\/div>\n

Pediatrics – infectology and antimicrobial therapy in critical illness.<\/span><\/p>\n<\/div>\n

\n
VISION<\/strong><\/div>\n

Improve the effectiveness of antimicrobial therapy and extend life expectancy in critically ill children.<\/span><\/p>\n<\/div>\n

\n
MISSION<\/strong><\/div>\n

Optimize antibiotic dosing based on serum drug levels and up–to–date evidence in critically ill children.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 1<\/strong><\/div>\n

Extended infusion of β–lactams reduces mortality and enhances microbiological eradication in paediatric patients: systematic review and meta–analysis.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 2<\/strong><\/div>\n

Comparison of efficacy and plasma concentrations of extended versus intermittent infusion of β–lactams in critically ill paediatric patients: randomized clinical trial protocol.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 3<\/strong><\/div>\n

Monitoring antimicrobial plasma concentrations at different points of the extracorporeal blood circuit during CKRT therapy.<\/span><\/p>\n<\/div>\n

\r\n
\r\n
\r\n
\r\n